Ha'Emek Medical Center
Afula, 18101, Israel
NCT Number: NCT00678028
Due to genetic polymorphism about 15%-30% of the world population have low levels of MBL (Mannose Binding Lectin) in serum (below 500ng/mL). Different studies reported correlation between polymorphism in the MBL gene with low levels of MBL in serum and higher frequency of recurrent infections, severity of sepsis, ARDS and other infections. Urinary Tract Infection (UTI) is one of the very common infection in women. Since MBL is part of the innate immunity and there are proofs of relation between patients with recurrent infections and lack of MBL, we decided to explore a possible relation between low levels of MBL and different genotypes of MBL in young women and the risk to develop recurrent UTI.
Looking for future studies?
Notify Me18 year–50 year
Female
Observational
Afula, 18101, Israel
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
HaEmek Medical Center, Israel
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07627412
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Nanjing, Jiangsu, China
View Trial DetailsNCT02246270
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Tulsa, Oklahoma, United States
View Trial DetailsNCT01663181
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Vienna, Austria
View Trial DetailsNCT02869165
Atrophic Vaginitis, Female Urogenital Diseases
Louisville, Kentucky, United States
View Trial Details